Surmodics Inc (SRDX): Market Cap to Revenue

Symbol and logo of brand Surmodics Inc (SRDX)

Surmodics, Inc. (SRDX) ensures a stable output of sterile catheters through its own manufacturing facilities in the US and Ireland. This price-to-sales chart from the GURU.Markets terminal shows the value has stabilized at 5.10. Revenues are based on licensing royalties for unique coatings. Strong pricing power and patents for chemical compositions minimize the risks of component substitution in partners' products.

SRDX Surmodics Inc P/S Multiple (07/04/2022 - 11/29/2025)

Analytical breakdowns for Surmodics Corp (SRDX)

- share price and consensus valuation forecast:
Price Performance Chart surmodics.com|SRDX - Price Target Chart
- stock exchange capitalization data:
Market Valuation Surmodics Corp|SRDX - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Surmodics|SRDX - Book Capitalization|Capitalization to Book Value Ratio surmodics.com|SRDX - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Surmodics, Inc.|SRDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Surmodics Inc.|SRDX - Company Aggregate Debts|Debts to Book Capitalization Surmodics Corp|SRDX - Company Long-Term Debt|Company Short-Term Debt Surmodics|Intermediate Coverage Ratio surmodics.com
- earnings and multiples data:
SRDX - Net Profit|Expected Net Profit Surmodics, Inc.|SRDX - Price to Earnings Ratio|Forward Price to Earnings Multiple Surmodics Inc|SRDX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Surmodics Corp|SRDX - Operating profit EBITDA|Net earnings per share for the last four quarters Surmodics|SRDX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months surmodics.com|SRDX - Earnings per share growth in current year|Expected earnings per share growth for next year Surmodics, Inc.
- issuer revenue and sales details:
SRDX - Revenue and Sales Volume|Company Expected Sales Volume surmodics.com|SRDX - Price-to-Revenue Ratio|Market Cap to Projected Revenue Surmodics Corp
General company analysis:SRDX surmodics.com
Core merchandise of Surmodics, Inc.

The P/S ratio compares the market capitalization of Surmodics, Inc. (SRDX) to its annual revenue, determining the value of each dollar of sales in the eyes of investors. Analyzing the P/S multiple can reveal asset overvaluation, particularly when the efficiency of chemical production outsourcing and cloud logistics fails to provide a proportional acceleration in the company's revenue growth rates.

Competitors of Surmodics, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|Market Cap to Revenue GCTK|P/S Multiple nanovibronix.com|Price-to-Revenue Ratio Venus Concept Corp (VERO)|NUWE (Nuwellis Corp) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Aethlon Medical AEMD|ASXC - Market Cap to Revenue|AVGR - Price-to-Revenue Ratio|Price to Sales BioSig|CUTR: P/S Multiple|Market Cap to Revenue Ratio KNW|NARI (Inari Medical, Inc.) - P/S Multiple|nevro.com (NVRO) - Price-to-Revenue Coefficient|P/S Multiple RSLS|Market Cap to Revenue Silk Road Medical, Inc. SILK